Dutasteride/Tadalafil
- Generic Name
- Dutasteride/Tadalafil
Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia
Phase 3
Completed
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- First Posted Date
- 2021-07-01
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Dongkook Pharmaceutical Co., Ltd.
- Target Recruit Count
- 667
- Registration Number
- NCT04947631
- Locations
- 🇰🇷
Ewha Womans University mokdong Hospital, Seoul, Korea, Republic of
Safety and Pharmacokinetic Characteristics of DKF-313
Phase 1
Completed
- Conditions
- HealthyBenign Prostate Hyperplasia
- Interventions
- First Posted Date
- 2015-02-02
- Last Posted Date
- 2021-07-06
- Lead Sponsor
- Dongkook Pharmaceutical Co., Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT02352311
- Locations
- 🇰🇷
Chonbuk National University Hospital, Jeonju, Jeollabuk-do, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath